PTC Therapeutics PTCT Cost Of Goods And Service Excluding Amortization Of Intangible Assets
Cost Of Goods And Service Excluding Amortization Of Intangible Assets at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept ptct:CostOfGoodsAndServiceExcludingAmortizationOfIntangibleAssets.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's cost of goods and service excluding amortization of intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's cost of goods and service excluding amortization of intangible assets?
- PTC Therapeutics (PTCT) reported cost of goods and service excluding amortization of intangible assets of $28.03M in Q1 2026.
- How has PTC Therapeutics's cost of goods and service excluding amortization of intangible assets changed year-over-year?
- PTC Therapeutics's cost of goods and service excluding amortization of intangible assets increased by 117.9% year-over-year, from $12.86M to $28.03M.
- What is the long-term trend for PTC Therapeutics's cost of goods and service excluding amortization of intangible assets?
- Over 2 years (2023 to 2025), PTC Therapeutics's cost of goods and service excluding amortization of intangible assets has grown at a -15.3% compound annual growth rate (CAGR), from $65.49M to $47.01M.
- What does cost of goods and service excluding amortization of intangible assets mean?
- This metric represents the direct costs incurred to manufacture and supply pharmaceutical products, excluding the non-cash amortization of acquired intangible assets. It captures the core variable costs of production, such as raw materials, labor, and manufacturing overhead. Monitoring this allows investors to assess the underlying gross margin efficiency of the company's commercialized product portfolio.